Germany-based Merck (NYSE: MRK) has announced the appointment of Marc Horn as its China unit president, effective as of January 1, 2024. Horn will take over from Allan Gabor, who is set to retire on December 31, 2023. In his new role, Horn will be responsible for formulating Merck’s development strategy in China, establishing cooperative relationships with local policymakers, partners, and clients, and promoting the company’s presence in major markets. He will be based in Shanghai and report directly to Kai Beckmann, CEO of Merck Electronics.
Allan Gabor’s Retirement and Marc Horn’s Background
Allan Gabor, the incumbent Merck China president, will conclude his tenure at the end of 2023. Marc Horn, who is currently serving as the Chief Transformation Officer of Merck Life Science China, is well-equipped to take on the role, with over 20 years of experience in business and finance across the United States, Germany, Singapore, and China. His deep understanding of diverse cultures, employee groups, and markets, coupled with excellent cross-cultural communication skills, positions him as an ideal leader for Merck’s China operations.
Horn’s Merck Career and Achievements
Horn joined Merck in 2014 and has since held various leadership positions, including the chief financial officer of Merck China, the chief financial officer of East Asia, the managing director of China biopharmaceutical business, and the chief financial officer of the life science business. His unique insights into different market operations and needs will be invaluable as he takes the helm of Merck’s China unit.-Fineline Info & Tech
